Taconic Capital Advisors’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Taconic Capital Advisors’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-250,000	Closed	-$14K	–	198
2023 Q3	$14K	Hold	250,000	–	–	﹤0.01%	126
2023 Q2	$36.3K	Hold	250,000	–	–	﹤0.01%	126
2023 Q1	$20K	Hold	250,000	–	–	﹤0.01%	208
2022 Q4	$7.5K	Hold	250,000	–	–	﹤0.01%	441
2022 Q3	$20K	Hold	250,000	–	–	﹤0.01%	521
2022 Q2	$15K	Hold	250,000	–	–	﹤0.01%	624
2022 Q1	$55K	Buy	+250,000	New	+$64.9K	﹤0.01%	550

Taconic Capital Advisors's BIOSW Position: Q4 2023 in Review

Taconic Capital Advisors sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 250,000 shares — an estimated $14K sold.

Taconic Capital Advisors first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $55K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Taconic Capital Advisors reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Taconic Capital Advisors sold 250,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $14K.
Taconic Capital Advisors first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Taconic Capital Advisors's BioPlus Acquisition Corp. Warrants position peaked at $55K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Taconic Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.